Target Price | $32.43 |
Price | $31.23 |
Potential | 3.86% |
Number of Estimates | 23 |
23 Analysts have issued a price target CSX 2026 . The average CSX target price is $32.43. This is 3.86% higher than the current stock price. The highest price target is $38.00 21.68% , the lowest is $27.00 13.54% . | |
A rating was issued by 28 analysts: 19 Analysts recommend CSX to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 3.86% . Most analysts recommend the CSX stock at Purchase. |
20 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.2b . This is 0.23% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $14.5b 1.67% , the lowest is $13.8b 3.38% .
This results in the following potential growth metrics:
2024 | $14.5b | 0.80% |
---|---|---|
2025 | $14.2b | 2.00% |
2026 | $14.9b | 4.50% |
2027 | $15.4b | 3.15% |
2028 | $16.4b | 6.63% |
2029 | $17.2b | 5.20% |
21 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $6.6b . This is 2.27% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.8b 2.94% , the lowest is $6.3b 5.32% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.0b | 1.02% |
---|---|---|
2025 | $6.6b | 6.97% |
2026 | $7.1b | 8.46% |
2027 | $7.4b | 4.29% |
2028 | $7.9b | 6.19% |
2029 | $8.4b | 6.53% |
2024 | 48.14% | 0.22% |
---|---|---|
2025 | 46.04% | 5.07% |
2026 | 47.79% | 3.80% |
2027 | 48.32% | 1.11% |
2028 | 48.12% | 0.41% |
2029 | 48.73% | 1.27% |
15 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.1b . This is 1.42% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.3b 2.34% , the lowest is $2.9b 9.36% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.4b | 1.65% |
---|---|---|
2025 | $3.1b | 7.48% |
2026 | $3.6b | 16.78% |
2027 | $3.9b | 6.90% |
2028 | $4.4b | 13.98% |
2029 | $5.1b | 15.85% |
2024 | 23.13% | 0.86% |
---|---|---|
2025 | 21.83% | 5.61% |
2026 | 24.40% | 11.77% |
2027 | 25.29% | 3.65% |
2028 | 27.03% | 6.88% |
2029 | 29.77% | 10.14% |
15 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.66 . This is 1.19% lower than earnings per share in the financial year 2024. The highest EPS forecast is $1.75 2.34% , the lowest is $1.55 9.36% .
This results in the following potential growth metrics and future valuations:
2024 | $1.79 | 1.65% |
---|---|---|
2025 | $1.66 | 7.26% |
2026 | $1.93 | 16.27% |
2027 | $2.07 | 7.25% |
2028 | $2.36 | 14.01% |
2029 | $2.73 | 15.68% |
Current | 18.61 | 2.16% |
---|---|---|
2025 | 18.86 | 1.34% |
2026 | 16.15 | 14.37% |
2027 | 15.11 | 6.44% |
2028 | 13.25 | 12.31% |
2029 | 11.44 | 13.66% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 5.41 and an P/S ratio of 4.12 .
This results in the following potential growth metrics and future valuations:
Current | 5.40 | 4.93% |
---|---|---|
2025 | 5.41 | 0.26% |
2026 | 5.18 | 4.31% |
2027 | 5.02 | 3.05% |
2028 | 4.71 | 6.21% |
2029 | 4.48 | 4.95% |
Current | 4.11 | 8.28% |
---|---|---|
2025 | 4.12 | 0.23% |
2026 | 3.94 | 4.31% |
2027 | 3.82 | 3.05% |
2028 | 3.58 | 6.21% |
2029 | 3.41 | 4.95% |
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | May 16 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | May 12 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Apr 17 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 17 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
May 16 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
May 12 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Apr 17 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 17 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.